Published in Biomaterials on September 05, 2016
Modular assembly of thick multifunctional cardiac patches. Proc Natl Acad Sci U S A (2017) 0.75
Human iPSC-derived myocardium-on-chip with capillary-like flow for personalized medicine. Biomicrofluidics (2017) 0.75
Towards engineering integrated cardiac organoids: beating recorded. J Thorac Dis (2016) 0.75
Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture. Biomaterials (2017) 0.75
The Role of Microfluidics for Organ on Chip Simulations. Bioengineering (Basel) (2017) 0.75
Cancer-on-a-chip systems at the frontier of nanomedicine. Drug Discov Today (2017) 0.75
3D Bioprinting and In Vitro Cardiovascular Tissue Modeling. Bioengineering (Basel) (2017) 0.75
How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov (2010) 14.09
Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res (2004) 8.41
Heart regeneration. Nature (2011) 5.91
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials (1999) 4.69
3D bioprinting of tissues and organs. Nat Biotechnol (2014) 4.66
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater (2012) 4.10
Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater (2008) 4.00
Induced pluripotent stem cells: past, present, and future. Cell Stem Cell (2012) 3.43
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med (2014) 3.23
Alginate hydrogels as biomaterials. Macromol Biosci (2006) 2.94
Vascularization in tissue engineering. Trends Biotechnol (2008) 2.93
Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res (2007) 2.74
Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A (2010) 2.58
3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater (2014) 2.54
Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano (2013) 2.23
Microengineered physiological biomimicry: organs-on-chips. Lab Chip (2012) 2.21
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods (2013) 2.14
Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol (2010) 2.01
Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01
Electrical stimulation systems for cardiac tissue engineering. Nat Protoc (2009) 1.97
Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov (2015) 1.95
Omnidirectional printing of 3D microvascular networks. Adv Mater (2011) 1.76
The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther (2011) 1.71
Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol (2004) 1.65
Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc (2008) 1.65
Functional Human Vascular Network Generated in Photocrosslinkable Gelatin Methacrylate Hydrogels. Adv Funct Mater (2012) 1.63
Scaling and systems biology for integrating multiple organs-on-a-chip. Lab Chip (2013) 1.58
25th anniversary article: Engineering hydrogels for biofabrication. Adv Mater (2013) 1.54
Microfluidic patterning for fabrication of contractile cardiac organoids. Biomed Microdevices (2007) 1.46
Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip (2013) 1.44
Synthesis and characterization of tunable poly(ethylene glycol): gelatin methacrylate composite hydrogels. Tissue Eng Part A (2011) 1.44
Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care. Am J Gastroenterol (2008) 1.35
Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip (2014) 1.34
Can pharmacogenetics help rescue drugs withdrawn from the market? Pharmacogenomics (2006) 1.27
Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials. Curr Top Med Chem (2008) 1.25
A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging. Lab Chip (2011) 1.22
Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun (2013) 1.20
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials (2015) 1.15
Building vascular networks. Sci Transl Med (2012) 1.14
Organ-on-a-chip platforms for studying drug delivery systems. J Control Release (2014) 1.06
Unforeseen decreases in dissolved oxygen levels affect tube formation kinetics in collagen gels. Am J Physiol Cell Physiol (2011) 1.05
Human iPSC-based cardiac microphysiological system for drug screening applications. Sci Rep (2015) 1.04
Highly Elastic Micropatterned Hydrogel for Engineering Functional Cardiac Tissue. Adv Funct Mater (2013) 1.04
Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction. Biomaterials (2014) 1.00
Transdermal regulation of vascular network bioengineering using a photopolymerizable methacrylated gelatin hydrogel. Biomaterials (2013) 1.00
Microfluidic Bioprinting of Heterogeneous 3D Tissue Constructs Using Low-Viscosity Bioink. Adv Mater (2015) 0.98
A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication (2016) 0.96
A cost-effective fluorescence mini-microscope for biomedical applications. Lab Chip (2015) 0.95
From cardiac tissue engineering to heart-on-a-chip: beating challenges. Biomed Mater (2015) 0.94
Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles. Small (2014) 0.93
Organs-on-a-chip for drug discovery. Curr Opin Pharmacol (2013) 0.93
Creating perfused functional vascular channels using 3D bio-printing technology. Biomaterials (2014) 0.93
Coaxial nozzle-assisted 3D bioprinting with built-in microchannels for nutrients delivery. Biomaterials (2015) 0.92
Seeking the right context for evaluating nanomedicine: from tissue models in petri dishes to microfluidic organs-on-a-chip. Nanomedicine (Lond) (2015) 0.92
Neovascularization in biodegradable inverse opal scaffolds with uniform and precisely controlled pore sizes. Adv Healthc Mater (2012) 0.92
Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells' therapeutic efficacy for myocardial infarction. ACS Nano (2015) 0.92
Three-dimensional filamentous human diseased cardiac tissue model. Biomaterials (2013) 0.91
Physiologically relevant organs on chips. Biotechnol J (2013) 0.91
Three-dimensional in vitro reaggregates of embryonic cardiomyocytes: a potential model system for monitoring effects of bioactive agents. J Biomol Screen (2005) 0.89
Tough and flexible CNT-polymeric hybrid scaffolds for engineering cardiac constructs. Biomaterials (2014) 0.88
Vascular endothelial growth factor secretion by nonmyocytes modulates Connexin-43 levels in cardiac organoids. Tissue Eng Part A (2012) 0.87
Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues. Lab Chip (2016) 0.86
Direct 3D bioprinting of perfusable vascular constructs using a blend bioink. Biomaterials (2016) 0.85
Multiple facets for extracellular matrix mimicking in regenerative medicine. Nanomedicine (Lond) (2015) 0.84
In vitro human tissue models--moving towards personalized regenerative medicine. Adv Drug Deliv Rev (2011) 0.84
Reduced Graphene Oxide-GelMA Hybrid Hydrogels as Scaffolds for Cardiac Tissue Engineering. Small (2016) 0.84
Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system. Acta Biomater (2014) 0.83
Decoupling the Direct and Indirect Biological Effects of ZnO Nanoparticles Using a Communicative Dual Cell-Type Tissue Construct. Small (2015) 0.83
Cardiac tissue engineering: current state and perspectives. Front Biosci (Landmark Ed) (2012) 0.82
Elastomeric free-form blood vessels for interconnecting organs on chip systems. Lab Chip (2016) 0.81
On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip. Sci Rep (2014) 0.81
Construction of three-dimensional vascularized cardiac tissue with cell sheet engineering. J Control Release (2014) 0.79
Tuning Endothelial Permeability with Functionalized Nanodiamonds. ACS Nano (2015) 0.79
A Bioactive Carbon Nanotube-Based Ink for Printing 2D and 3D Flexible Electronics. Adv Mater (2016) 0.77
Boosting clinical translation of nanomedicine. Nanomedicine (Lond) (2016) 0.77
Microfabric Vessels for Embryoid Body Formation and Rapid Differentiation of Pluripotent Stem Cells. Sci Rep (2016) 0.76
In vitro and in vivo assessment of heart-homing porous silicon nanoparticles. Biomaterials (2016) 0.76
Chemotaxis-driven assembly of endothelial barrier in a tumor-on-a-chip platform. Lab Chip (2016) 0.76
Elastomeric free-form blood vessels for interconnecting organs on chip systems. Lab Chip (2016) 0.81